Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Fetzima
2. Levomilnacipran
1. 175131-60-9
2. Milnacipran Hydrochloride
3. (1s-cis)-milnacipran Hydrochloride
4. Fetzima
5. F 2695 Hydrochloride
6. 101152-94-7
7. Milnacipran ((1s-cis) Hydrochloride)
8. Milnacipran (1s-cis) Hydrochloride
9. Levomilnacipran Hcl
10. F2695 Hydrochloride
11. Levomilnacipran Hydrochloride [usan]
12. F-2695 Hydrochloride
13. 371u2zk31u
14. (1s,2r)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride
15. (1s-cis)-milnacipran Hcl
16. (1s,2r)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride
17. Levomilnacipran Hydrochloride (usan)
18. Cyclopropanecarboxamide, 2-(aminomethyl)-n,n-diethyl-1-phenyl-, Hydrochloride (1:1), (1s,2r)-
19. Midalcipran Hydrochloride
20. Rac-milnacipran Hydrochloride
21. Joncia
22. Unii-371u2zk31u
23. L-milnacipran Hcl
24. (1s,2r)-milnacipran Hydrochloride
25. Fetzima (tn)
26. Tn-912
27. Schembl1148742
28. Chembl2105732
29. Hy-b0168b
30. Milnacipran Hydrochloride Solution
31. Dtxsid801026201
32. Amy10333
33. Mfcd18433402
34. S5693
35. Akos025311514
36. Ccg-231710
37. Cs-4972
38. (1s,2r)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropane-1-carboxamide Hydrochloride
39. As-12868
40. M2133
41. Milnacipran Hydrochloride, (1s,2r)-
42. Levomilnacipran Hydrochloride [who-dd]
43. A14391
44. C13985
45. C73344
46. D10133
47. F-2207
48. 152m947
49. A899431
50. Levomilnacipran Hydrochloride [orange Book]
51. Q27256611
52. Milnacipran Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
Molecular Weight | 282.81 g/mol |
---|---|
Molecular Formula | C15H23ClN2O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Exact Mass | 282.1498911 g/mol |
Monoisotopic Mass | 282.1498911 g/mol |
Topological Polar Surface Area | 46.3 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 295 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Fetzima |
PubMed Health | Levomilnacipran (By mouth) |
Drug Classes | Antidepressant |
Active Ingredient | Levomilnacipran hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | eq 40mg base; eq 80mg base; eq 120mg base; eq 20mg base |
Market Status | Prescription |
Company | Forest Labs |
2 of 2 | |
---|---|
Drug Name | Fetzima |
PubMed Health | Levomilnacipran (By mouth) |
Drug Classes | Antidepressant |
Active Ingredient | Levomilnacipran hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | eq 40mg base; eq 80mg base; eq 120mg base; eq 20mg base |
Market Status | Prescription |
Company | Forest Labs |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Serotonin and Noradrenaline Reuptake Inhibitors
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Milnacipran HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milnacipran HCl, including repackagers and relabelers. The FDA regulates Milnacipran HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milnacipran HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Milnacipran HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Milnacipran HCl supplier is an individual or a company that provides Milnacipran HCl active pharmaceutical ingredient (API) or Milnacipran HCl finished formulations upon request. The Milnacipran HCl suppliers may include Milnacipran HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Milnacipran HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Milnacipran HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Milnacipran HCl active pharmaceutical ingredient (API) in detail. Different forms of Milnacipran HCl DMFs exist exist since differing nations have different regulations, such as Milnacipran HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Milnacipran HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Milnacipran HCl USDMF includes data on Milnacipran HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Milnacipran HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Milnacipran HCl suppliers with USDMF on PharmaCompass.
A Milnacipran HCl written confirmation (Milnacipran HCl WC) is an official document issued by a regulatory agency to a Milnacipran HCl manufacturer, verifying that the manufacturing facility of a Milnacipran HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Milnacipran HCl APIs or Milnacipran HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Milnacipran HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Milnacipran HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Milnacipran HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Milnacipran HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Milnacipran HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Milnacipran HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Milnacipran HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Milnacipran HCl suppliers with NDC on PharmaCompass.
Milnacipran HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milnacipran HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milnacipran HCl GMP manufacturer or Milnacipran HCl GMP API supplier for your needs.
A Milnacipran HCl CoA (Certificate of Analysis) is a formal document that attests to Milnacipran HCl's compliance with Milnacipran HCl specifications and serves as a tool for batch-level quality control.
Milnacipran HCl CoA mostly includes findings from lab analyses of a specific batch. For each Milnacipran HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milnacipran HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Milnacipran HCl EP), Milnacipran HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milnacipran HCl USP).
LOOKING FOR A SUPPLIER?